Tightening capital markets, fluctuating energy prices and increased environmental concerns are factors that are driving pharmaceutical processors to revisit their energy strategies in an effort to optimize cost savings
Table: Energy consumption in pharma industry |
S.No. |
Application |
Bulk Drug units |
Formulation Units |
A). Power |
|
Process needs |
|
|
Reactors, Mixers, pumps, centrifuges , dryers in API units |
30% |
|
Mixers, tabletting machines, packing machines in formulation units |
|
40% |
Utilities |
|
|
Pumps, Refrigeration |
45% |
5% |
HVAC systems |
10% |
40 % |
Lighting |
5% |
10% |
Office and other uses |
5% |
5% |
B). Fuel (Coal & Furnace oil ) |
|
To generate steam for process needs |
100% |
100% |
|
| |
| The cost of energy is not a major part of the production cost. However spiraling prices of energy and the national prerogative of energy saving has made energy conservation an important parameter in development of this industry. There is considerable scope for energy saving in the pharma SMEs. The industry is aware of the possibilities but shy of making the investment in adopting energy saving equipment. |
|
| |
| |
| |
| |
|
